[1] Zhang Guangping, Xie Huaning,.Update Highlights from 2018 China Heart Failure Diagnosis and Treatment Guide [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2020, (01): 40-42,61. [doi: 10.13424/j.cnki.jsctcm.2020.01.011]
Update Highlights from 2018 China Heart Failure Diagnosis and Treatment Guide
- Article number:
- 2096-1340(2020)01-0040-04
- Keywords:
- heart failure; the “ Guide” ; highlights; Ejection Fraction ( EF)
- ZTFLH:
- R2-09
- Code:
- B
- Abstract:
- 2018 China Heart Failure Diagnosis and Treatment Guide features new, complete and authentic content with Chinese characteristic. It adopts new classification and diagnostic criteria for heart failure, and emphasizes the early screening, early diagnosis and strengthened prevention. New drugs are used in the treatment, and comprehensive management of heart failure is also emphasized. The 2018 Heart Failure Diagnosis and Treatment Guide has many highlights, fully geared to the international standards. Meanwhile, it combines domestic representative clinical evidence - based medical evidence to comprehensively cover the entire diagnosis and treatment of heart failure development, laying a foundation for the standardization of heart failure diagnosis and treatment in China. The new Guide( 2018 Heart Failure Diagnosis and Treatment Guide) will enable more doctors to use the latest treatment concepts, methods and means for standardized treatment, improve the rate of reaching the standard, and truly benefit patients.
References:
[1]Brenyo A, Barsheshet A, Kutyifa V, et al. Predictors of spontaneous reverse remodeling in mild heart failure patients with left ventricular dysfunction [ J] . Circ Heart Fail, 2014, 7( 4) :565 -572.
[2] Braunwald E. The war against heart failure: the Lancet lecture. Lancet. Lancet 2015; 385: 812- 24.
[3] Dhalla N S, Rangi S, Babick A P, et al. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging[ J] . Heart Fail Rev, 2012, 17( 4 -5) :671 -681.
[4] Dhalla N S, Saini H K, Tappia P S, et al. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease[ J] . J Cardiovasc Med ( Hagerstown) , 2007, 8( 4) : 238 -250.
[5]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南 2018[J].中华心血管病杂志,2018,46(10):760-789.
[6]中华医学会心血管病分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南 2014[J].中华心血管病杂志,2014,42(2):98-122.
[7] Ksi czyk M, Lelonek M. Angiotensin eceptor/ neprilysin inhibitor - a breakthrough in chronic heart failure therapy:summary of subanalysis on PARADIGM - HF trial findings. Heart Fail Rev[ J] . 2019, [ Epub ahead of print].
[8]王永霞,朱明军.中医药防治慢性心力衰竭的研究思考[J].中华中医药杂志,2012,27(7):1868-1870.
Memo
基金项目：国家中医药管理局第三届国医大师／全国名中医传承工作室建设项目（国中医药办人教函（2018）119号）